drugset / Trial / NCT02351115
Staccato Alprazolam and Photoparoxysmal Response
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether people who usually have photosensitive epilepsy will show a reduction in epileptic activity when they take a single dose of Staccato Alprazolam as compared to placebo.
Timeline
- Start
- 2015-01
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprazolam | Small molecule | 0.5 mg | Inhaled |
| Subject | Alprazolam | Small molecule | 1 mg | Inhaled |
| Subject | Alprazolam | Small molecule | 2 mg | Inhaled |